Advertisement

Topics

AlphaHelix Molecular Diagnostics AB Company Profile

19:28 EST 23rd November 2017 | BioPortfolio


News Articles [1138 Associated News Articles listed on BioPortfolio]

AlphaHelix Molecular Diagnostics AB ALPH Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummaryAlphaHelix Molecular Diagnostics AB AlphaHelix is a developer, manufacturer, and marketer of DNA identification products. The company provides smarter reagents, consumables, and instruments for...

Hologic: Market Shares and Competitive Position by Product and CountryPerformance, Capabilities, Goals and Strategies in the Global Diagnostics Industry [Report Updated: 24082017] Prices from USD $4500

This unique market intelligence report from LeadingMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates b...

Hummingbird Diagnostics and Saarland University Collaborate in Early Disease Detection Based on Molecular Markers

Hummingbird Diagnostics GmbH, specialized in early disease detection using molecular markers derived from blood, and Saarland University agreed on a comprehensive framework agreement regarding an expa...

Danaher Strengthens Molecular Diagnostics Portfolio with $4B Acquisition of Cepheid

Danaher has announced the acquisition of medical diagnostics company Cepheid, bolstering their presence in the Molecular Diagnostics market. Danaher Corporation will pay $53 per share in cash, a premi...

IPO nets $6.4mm for Co-Diagnostics

Molecular diagnostics start-up Co-Diagnostics Inc. netted $6.4mm through its initial public offering of 1.18mm common shares at $6 each on the Nasdaq.

AMP to recognize Andrew P. Feinberg, M.D., M.P.H. with 2017 Award for Excellence in Molecular Diagnostics

(Association for Molecular Pathology) The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, today announced that Andrew...

AMP Iissues consensus guideline recommendations for NGS bioinformatics pipelines

(Association for Molecular Pathology) The Association for Molecular Pathology, the premier global, non-profit molecular diagnostics professional society, today published 17 consensus recommendations t...

2017 Molecular Diagnostics Market: Supplier Shares, Sales Forecasts and Facilities by Country [Report Updated: 23082017] Prices from USD $2450

This report provides: Worldwide overview of the molecular diagnostics market, including France, Germany, Italy, Japan, Spain, UK and USA. Estimates of facilities performing DNA sequencing and molecula...

Drugs and Medications [24 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]

Oxygen

Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [1001 Associated PubMed Articles listed on BioPortfolio]

Component resolved diagnostics for hymenoptera venom allergy.

Component-resolved diagnostics makes use of defined allergen molecules to analyse IgE-mediated sensitizations at a molecular level. Here, we review recent studies on the use of component-resolved diag...

Molecular diagnostics of ALK-positive lung cancer.

ALK translocation is the 3rd most frequent genetic aberration in lung adenocarcinoma, and several inhibitors are now clinically available in first and second line settings. Accordingly, molecular diag...

Comprehensive genetic study of cystic fibrosis in Slovak patients in 25 years of genetic diagnostics.

Cystic fibrosis (CF) has one of the longest histories in hereditary disease molecular diagnostics. However, identification of causative mutations in the CFTR gene is complicated by over two thousand c...

Advances in point-of-care technologies for molecular diagnostics.

Advances in miniaturization, nanotechnology, and microfluidics, along with developments in cloud-connected point-of-care (POC) diagnostics technologies are pushing the frontiers of POC devices toward ...

Use of multiplex PCR based molecular diagnostics in diagnosis of suspected CNS infections in tertiary care setting-A retrospective study.

CNS infections like meningitis and encephalitis pose enormous healthcare challenges due to mortality, sequelae and socioeconomic burden. In tertiary setting, clinical, microbiological, cytological and...

Clinical Trials [1257 Associated Clinical Trials listed on BioPortfolio]

Feasibility of Molecular Biology in Pancreatic Cyst Tumors

The main objective of the study is to compare the diagnostic accuracy of intra-cystic fluid DNA molecular analysis to standard diagnostics. The secondary objective of the study is to eval...

Genetic Analysis of Liver Cancer

Liver cancer is a leading cause of cancer deaths worldwide. While the molecular pathogenesis of liver cancer has been extensively studied, less is known about how the molecular biology of ...

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

DIAgnostics for Multidrug Resistant Tuberculosis in Africa

Recent advances in molecular diagnostics of tuberculosis, especially the GeneXpert Mycobacterium tuberculosis/Rifampicin test have reduced the time to diagnose Rifampicin Resistant Tubercu...

Conventional and Molecular Diagnostic Method for Patients With Suspected UTI

In this protocol, the investigators are examining the use of a novel pathogen testing technology and method of identification of antibiotic susceptibility against the conventional C & S te...

Companies [1577 Associated Companies listed on BioPortfolio]

AlphaHelix Molecular Diagnostics AB

AlphaHelix

AlphaHelix develops, manufactures and markets productsf or DNA-identification and quantitation. Its proprietary SuperConvection technology makes it feasible to carry out state-of-the-art methods for P...

HTG Molecular Diagnostics

HTG Molecular Diagnostics is a leading provider of molecular-based solutions for gene expression profiling, miRNA and mRNA measurement, translational medicine and diagnostic appli...

Third Wave Technologies

Third Wave is a growing leader in molecular diagnostics, providing DNA and RNA analysis products to clinical, research, and agricultural customers. Our company is one of the only companies in the mole...

Blue Earth Diagnostics Ltd.

Blue Earth Diagnostics is a molecular imaging diagnostics company focused on the development and commercialization of novel PET imaging agents to inform clinical management and gu...

More Information about "AlphaHelix Molecular Diagnostics AB" on BioPortfolio

We have published hundreds of AlphaHelix Molecular Diagnostics AB news stories on BioPortfolio along with dozens of AlphaHelix Molecular Diagnostics AB Clinical Trials and PubMed Articles about AlphaHelix Molecular Diagnostics AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AlphaHelix Molecular Diagnostics AB Companies in our database. You can also find out about relevant AlphaHelix Molecular Diagnostics AB Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record